A biotechnology company called Calysta, based in Menlo Park, California, is set to announce the first ever large-scale factory that uses microbes to turn natural gas – methane – into a high-protein food for the animals we eat. The factory which will be built in the US in collaboration with food-giant Cargill, will produce 200,000 tonnes of feed a year.
Elanco’s novel in-feed treatment has been approved for the prevention and control of sea lice in salmon and trout in Chile. The approval follows the completion of a series of studies, demonstrating its efficacy against Caligus rogercresseyi, the most common louse species impacting salmonid farms in Chile. The study demonstrated that salmon treated with the medication remained below the Chilean industry regulated threshold for an extended period of time, compared to the untreated group, which exceeded the threshold five times in the same period. “Managing these parasites is a constant strain on salmon farmers – it is time consuming, cumbersome, and stressful to both fish and farmers. This option can help provide relief from sea lice management for an extended period of time, alleviating that stress.”
BühlerAeroglide has appointed Paul Branson Director of Product Management. In this role Branson will focus on increasing quality, reducing production cycles, and developing advanced products and solutions. Most recently, Branson served as Product Manager for Aeroglide’s global industrial markets.